© 1995 by Oxford University Press
Journal of the National Cancer Institute, Vol. 87, No. 22, 1681-1685,
November 15, 1995
© 1995 Oxford University Press
Proportion of Breast Cancer Cases in the United States Explained by Well-Established Risk Factors
Environmental Epidemiology Branch, Epidemiology and Biostatistics Program, Division of Cancer Etiology, National Cancer Institute Bethesda, MD
Biostatistics Branch, Epidemiology and Biostatistics Program, Division of Cancer Etiology, National Cancer Institute Bethesda, MD
M. Patricia Madigan, B.S., National Institutes of Health, Executive Plaza North, Rm. 443, Bethesda, MD 20892.
BACKGROUND: Few estimates of the fraction of cases of breast cancer attributable to recognized risk factors have been published. All estimates are based on selected groups, making their generalizability to the U.S. population uncertain.
PURPOSE: Our goal was to estimate the fraction of breast cancer cases in the United States attributable to well-established risk factors (i.e., later age at first birth, nulliparity, higher family income, and first-degree family history of breast cancer), using data from the first National Health and Nutrition Examination Survey (NHANES I) Epidemiologic Follow-up Study (NHEFS), the survey and follow-up of a probability sample of the U.S. population.
METHODS: From a cohort of 7508 female participants surveyed in the early 1970s, and followed up between 1982 and 1984 and again in 1987, 193 breast cancer cases were accrued for study. We calculated incidence rates, relative risks (RRs), and population attributable risks (PARs) for breast cancer risk factors and extended our results to the U.S. female population by using sample weights from the NHANES I survey.
RESULTS: Our PAR estimates suggest that later age at first birth and nulliparity accounted for a large fraction of U.S. breast cancer cases, 29.5% (95% confidence interval [CI] = 5.6%–53.3%); higher income contributed 18.9% (95% CI = –4.3% to 42.1%), and family history of breast cancer accounted for 9.1% (95% CI = 3.0%–15.2%). Taken together, these well-established risk factors accounted for approximately 47% (95% CI = 17%–77%) of breast cancer cases in the NHEFS cohort and about 41% (95% CI = 2%–80%) in the U.S. population.
CONCLUSIONS: The RRs for most of these risk factors were modest, but their prevalence as a group was high, leading to estimates that suggest that a substantial proportion of breast cancer cases in the United States are explained by well-established risk factors.
IMPLICATIONS: Elucidation of the determinants underlying recognized factors and study of other factors that may confer risk or protection are needed in efforts to advance understanding of breast cancer etiology and to aid in devising strategies for prevention. [J Natl Cancer Inst 1987;87:1681–5]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. F. Anderson, I. Jatoi, and M. E. Sherman Qualitative Age Interactions in Breast Cancer Studies: Mind the Gap J. Clin. Oncol., November 10, 2009; 27(32): 5308 - 5311. [Full Text] [PDF]
|
|
|
|
 |
|
 R. G Stevens Light-at-night, circadian disruption and breast cancer: assessment of existing evidence Int. J. Epidemiol., August 1, 2009; 38(4): 963 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Thygesen, P. Mikkelsen, T. V. Andersen, H. Tonnesen, K. Juel, U. Becker, and M. Gronbaek Cancer Incidence among Patients with Alcohol Use Disorders--Long-Term Follow-Up Alcohol Alcohol., July 1, 2009; 44(4): 387 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Yi, J. W. Chang, W. Han, J. W. Lee, E. Ko, D. H. Kim, J.-Y. Bae, J. Yu, C. Lee, M.-H. Yu, et al. Autoantibody to Tumor Antigen, Alpha 2-HS Glycoprotein: A Novel Biomarker of Breast Cancer Screening and Diagnosis Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1357 - 1364. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Jorgensen, K. J. Helzlsouer, S. C. Clipp, J. H. Bolton, R. M. Crum, and K. Visvanathan DNA Repair Gene Variants Associated with Benign Breast Disease in High Cancer Risk Women Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 346 - 350. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Palma, S. M. Domchek, J. Stopfer, J. Erlichman, J. D. Siegfried, J. Tigges-Cardwell, B. A. Mason, T. R. Rebbeck, and K. L. Nathanson The Relative Contribution of Point Mutations and Genomic Rearrangements in BRCA1 and BRCA2 in High-Risk Breast Cancer Families Cancer Res., September 1, 2008; 68(17): 7006 - 7014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. Sprague, A. Trentham-Dietz, K. M. Egan, L. Titus-Ernstoff, J. M. Hampton, and P. A. Newcomb Proportion of Invasive Breast Cancer Attributable to Risk Factors Modifiable after Menopause Am. J. Epidemiol., August 15, 2008; 168(4): 404 - 411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ji, J. Olson, J. Zhang, M. Hildebrandt, L. Wang, J. Ingle, Z. Fredericksen, T. Sellers, W. Miller, J. M. Dixon, et al. Breast Cancer Risk Reduction and Membrane-Bound Catechol O-Methyltransferase Genetic Polymorphisms Cancer Res., July 15, 2008; 68(14): 5997 - 6005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Veselik, S. Divekar, S. Dakshanamurthy, G. B. Storchan, J. M.A. Turner, K. L. Graham, L. Huang, A. Stoica, and M. B. Martin Activation of Estrogen Receptor-{alpha} by the Anion Nitrite Cancer Res., May 15, 2008; 68(10): 3950 - 3958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Rose, S. M. Haffner, and J. Baillargeon Adiposity, the Metabolic Syndrome, and Breast Cancer in African-American and White American Women Endocr. Rev., December 1, 2007; 28(7): 763 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Rao, T. Poutahidis, J. G. Fox, and S. E. Erdman Breast Cancer: Should Gastrointestinal Bacteria Be on Our Radar Screen? Cancer Res., February 1, 2007; 67(3): 847 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. O'Leary, E. R. Schoenfeld, R. G. Stevens, G. C. Kabat, K. Henderson, R. Grimson, M. D. Gammon, M. C. Leske, and for the Electromagnetic Fields and Breast Cancer o Shift Work, Light at Night, and Breast Cancer on Long Island, New York Am. J. Epidemiol., August 15, 2006; 164(4): 358 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cazzaniga, G. Severi, C. Casadio, L. Chiapparini, U. Veronesi, and A. Decensi Atypia and ki-67 expression from ductal lavage in women at different risk for breast cancer. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1311 - 1315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Sokhansanj and D. M. Wilson III Estimating the effect of human base excision repair protein variants on the repair of oxidative DNA base damage. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 1000 - 1008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Kurian, M. A. Mills, M. Jaffee, B. M. Sigal, N. M. Chun, K. E. Kingham, L. C. Collins, K. W. Nowels, S. K. Plevritis, J. E. Garber, et al. Ductal Lavage of Fluid-Yielding and Non-Fluid-Yielding Ducts in BRCA1 and BRCA2 Mutation Carriers and Other Women at High Inherited Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1082 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Kenney, Y. Yasui, P. D. Inskip, S. Hammond, J. P. Neglia, A. C. Mertens, A. T. Meadows, D. Friedman, L. L. Robison, and L. Diller Breast Cancer after Childhood Cancer: A Report from the Childhood Cancer Survivor Study Ann Intern Med, October 19, 2004; 141(8): 590 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Glaser, J. L. Hsu, and M. L. Gulley Epstein-Barr Virus and Breast Cancer: State of the Evidence for Viral Carcinogenesis Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 688 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Martino, J. Costantino, M. McNabb, J. Mershon, K. Bryant, T. Powles, and R. J. Secrest The Role of Selective Estrogen Receptor Modulators in the Prevention of Breast Cancer: Comparison of the Clinical Trials Oncologist, April 1, 2004; 9(2): 116 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Steingart, M. Cotterchio, N. Kreiger, and M. Sloan Antidepressant medication use and breast cancer risk: a case-control study Int. J. Epidemiol., December 1, 2003; 32(6): 961 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. R. Smith, E. A. Levine, N. D. Perrier, M. S. Miller, R. I. Freimanis, K. Lohman, L. D. Case, J. Xu, H. W. Mohrenweiser, and J. J. Hu DNA-Repair Genetic Polymorphisms and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1200 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wooster and B. L. Weber Breast and Ovarian Cancer N. Engl. J. Med., June 5, 2003; 348(23): 2339 - 2347. [Full Text] [PDF]
|
|
|
|
 |
|
 T. R. Smith, M. S. Miller, K. K. Lohman, L.D. Case, and J. J. Hu DNA damage and breast cancer risk Carcinogenesis, May 1, 2003; 24(5): 883 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Faraglia, S. Y. Chen, M. D. Gammon, Y. Zhang, S. L. Teitelbaum, A. I. Neugut, H. Ahsan, G. C. Garbowski, H. Hibshoosh, D. Lin, et al. Evaluation of 4-aminobiphenyl-DNA adducts in human breast cancer: the influence of tobacco smoke Carcinogenesis, April 1, 2003; 24(4): 719 - 725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Glaser Correspondence re: Yasui et al., Breast Cancer Risk and "Delayed" Primary Epstein-Barr Virus Infection. 10: 9-16, 2001 Cancer Epidemiol. Biomarkers Prev., January 1, 2003; 12(1): 73 - 73. [Full Text] [PDF]
|
|
|
|
|
|
K. Hemminki and K. Czene Attributable Risks of Familial Cancer from the Family-Cancer Database Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1638 - 1644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Conway, S. N. Edmiston, L. Cui, S. S. Drouin, J. Pang, M. He, C.-K. Tse, J. Geradts, L. Dressler, E. T. Liu, et al. Prevalence and Spectrum of p53 Mutations Associated with Smoking in Breast Cancer Cancer Res., April 1, 2002; 62(7): 1987 - 1995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Davis and P. S. Webster The Social Context of Science: Cancer and the Environment The ANNALS of the American Academy of Political and Social Science, January 1, 2002; 584(1): 13 - 34. [Abstract] [PDF]
|
|
|
|
|
|
M. Cotterchio, N. Kreiger, M. Sloan, and A. Steingart Nonsteroidal Anti-inflammatory Drug Use and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., November 1, 2001; 10(11): 1213 - 1217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Stefanek, L. Hartmann, and W. Nelson Risk-Reduction Mastectomy: Clinical Issues and Research Needs J Natl Cancer Inst, September 5, 2001; 93(17): 1297 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Benichou A review of adjusted estimators of attributable risk Statistical Methods in Medical Research, June 1, 2001; 10(3): 195 - 216. [Abstract] [PDF]
|
|
|
|
|
|
M. Clemons and P. Goss Estrogen and the Risk of Breast Cancer N. Engl. J. Med., January 25, 2001; 344(4): 276 - 285. [Full Text] [PDF]
|
|
|
|
|
|
H. Anderson, A. Bladstrom, H. Olsson, and T. R. Moller Familial Breast and Ovarian Cancer: A Swedish Population-based Register Study Am. J. Epidemiol., December 15, 2000; 152(12): 1154 - 1163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Stellman, M. V. Djordjevic, J. A. Britton, J. E. Muscat, M. L. Citron, M. Kemeny, E. Busch, and L. Gong Breast Cancer Risk in Relation to Adipose Concentrations of Organochlorine Pesticides and Polychlorinated Biphenyls in Long Island, New York Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1241 - 1249. [Abstract] [Full Text]
|
|
|
|
|
|
A. Rundle, D. Tang, J. Zhou, S. Cho, and F. Perera The Association between Glutathione S-Transferase M1 Genotype and Polycyclic Aromatic Hydrocarbon-DNA Adducts in Breast Tissue Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1079 - 1085. [Abstract] [Full Text]
|
|
|
|
|
|
A. Rundle, D. Tang, H. Hibshoosh, A. Estabrook, F. Schnabel, W. Cao, S. Grumet, and F. P. Perera The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer Carcinogenesis, July 1, 2000; 21(7): 1281 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Yager Chapter 3: Endogenous Estrogens as Carcinogens Through Metabolic Activation J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 67 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Armstrong, A. Eisen, and B. Weber Assessing the Risk of Breast Cancer N. Engl. J. Med., February 24, 2000; 342(8): 564 - 571. [Full Text] [PDF]
|
|
|
|
|
|
S. L. Wolden, S. L. Hancock, R. W. Carlson, D. R. Goffinet, S. S. Jeffrey, and R. T. Hoppe Management of Breast Cancer After Hodgkin’s Disease J. Clin. Oncol., February 14, 2000; 18(4): 765 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Garcia-Closas, K. T. Kelsey, S. E. Hankinson, D. Spiegelman, K. Springer, W. C. Willett, F. E. Speizer, and D. J. Hunter Glutathione S-Transferase Mu and Theta Polymorphisms and Breast Cancer Susceptibility J Natl Cancer Inst, November 17, 1999; 91(22): 1960 - 1964. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V C. Jordan and M Morrow Raloxifene as a multifunctional medicine? BMJ, August 7, 1999; 319(7206): 331 - 332. [Full Text]
|
|
|
|
|
|
B. I. Graubard and E. L. Korn Analyzing Health Surveys for Cancer-Related Objectives J Natl Cancer Inst, June 16, 1999; 91(12): 1005 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Cummings, S. Eckert, K. A. Krueger, D. Grady, T. J. Powles, J. A. Cauley, L. Norton, T. Nickelsen, N. H. Bjarnason, M. Morrow, et al. The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial JAMA, June 16, 1999; 281(23): 2189 - 2197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. C. Jordan and M. Morrow Tamoxifen, Raloxifene, and the Prevention of Breast Cancer Endocr. Rev., June 1, 1999; 20(3): 253 - 278. [Abstract] [Full Text]
|
|
|
|
|
|
C. B. Ambrosone, J. L. Freudenheim, P. A. Thompson, E. Bowman, J. E. Vena, J. R. Marshall, S. Graham, R. Laughlin, T. Nemoto, and P. G. Shields Manganese Superoxide Dismutase (MnSOD) Genetic Polymorphisms, Dietary Antioxidants, and Risk of Breast Cancer Cancer Res., February 1, 1999; 59(3): 602 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. N. Hortobagyi Treatment of Breast Cancer N. Engl. J. Med., October 1, 1998; 339(14): 974 - 984. [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, D. P. Kiel, B. E. Kreger, L. A. Cupples, R. C. Ellison, J. F. Dorgan, A. Schatzkin, D. Levy, and D. T. Felson Bone Mass and the Risk of Breast Cancer among Postmenopausal Women N. Engl. J. Med., February 27, 1997; 336(9): 611 - 617. [Abstract] [Full Text] [PDF]
|
|